Shanghai, China

Wei-hong Yang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethypharm, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-hong Yang. Retrieved from https://idiyas.com/inventor/wei-hong-yang-kbmwczsg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wei-hong Yang in Herbal Drug Formulation

Introduction

Wei-hong Yang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of herbal medicine, particularly through his innovative formulations. His work focuses on creating stable and effective drug formulations that enhance the therapeutic benefits of herbal extracts.

Latest Patents

Wei-hong Yang holds a patent for "Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these." This invention presents a new stable herbal drug formulation in the form of sustained-release microgranules. The process for preparing these microgranules is also detailed in the patent, showcasing his expertise in pharmaceutical formulation.

Career Highlights

Yang is currently associated with Ethypharm, Inc., where he continues to develop innovative drug formulations. His work has been instrumental in advancing the use of herbal extracts in modern medicine. With a focus on sustainability and efficacy, he aims to improve patient outcomes through his inventions.

Collaborations

Some of his notable coworkers include Dominique Marechal and Yu-zhang Hu. Their collaborative efforts contribute to the research and development of new pharmaceutical products.

Conclusion

Wei-hong Yang's contributions to herbal drug formulation exemplify the intersection of traditional medicine and modern pharmaceutical science. His innovative approach continues to pave the way for new therapeutic options in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…